Tirzepatide
Tirzepatide is a dual agonist at the GIP and GLP-1 receptors, sitting between the single- and triple-receptor compounds on the same shelf.
Volume discounts up to 35% off — buy more, save more.
Orders of three or more vials include a 5 ml vial of bacteriostatic water, complimentary. Also available separately, $10.
Volume Pricing — tap a tier to set quantity
Research use only. Not for human or veterinary use. Not FDA approved. Supplied as lyophilized powder in a sterile vial for in-vitro laboratory research by qualified professionals.
Certificate of Analysis — Batch Documentation
Batch history
Each lot is independently analyzed before release. The figures above are taken directly from the lab report for the batch currently shipping; the report itself is available on request.
Storage & Stability — Research Handling Guidance
- 🧊Lyophilized (sealed vial): store at −20 °C; typically stable 24+ months.
- ❄️Reconstituted: refrigerate at 2–8 °C and use within ~30 days.
- 🔄Avoid repeated freeze/thaw cycles — aliquot before freezing if needed.
- 🌞Protect from light — keep the vial in its carton or amber storage.
General peptide storage guidance for laboratory settings. Research use only — not for human or veterinary use.
About Tirzepatide
Tirzepatide is a synthetic peptide that engages two incretin receptors at once: the receptor for glucose-dependent insulinotropic polypeptide, and the receptor for glucagon-like peptide-1. Holding both targets in a single molecule is the whole point of the design, and it is what places tirzepatide between semaglutide's single-receptor activity and retatrutide's three.
In the laboratory it is examined in work on insulin signalling, glucose regulation, lipid metabolism and body composition. It is supplied as a lyophilized powder for reconstitution in a suitable solvent under controlled conditions, at ≥98% purity, with the Certificate of Analysis for the current lot available on request. Sold for laboratory research use only; not for human or veterinary use.
Tirzepatide — Frequently Asked Questions
What is Tirzepatide?
Tirzepatide is a dual agonist at the GIP and GLP-1 receptors, sitting between the single- and triple-receptor compounds on the same shelf. It is identified by CAS number 2023788-19-2, a molecular weight of ~4813.5 g/mol.
What purity is Tirzepatide supplied at, and can the analysis be seen?
The lot currently in stock was assayed at 99.1% by HPLC. The Certificate of Analysis recording that figure is available on request.
In what form does Tirzepatide arrive, and how should it be kept?
Tirzepatide arrives as a lyophilized powder in a sterile vial. Keep the powder cold and out of the light. Once it has been reconstituted for research, refrigerate it and handle it according to standard peptide-stability practice.
Which quantities of Tirzepatide are stocked, and what do they cost?
Tirzepatide is stocked in 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg. Pricing begins at $70.00 per vial and falls on larger quantities, by up to 35%. US shipping is free on every order.
Can Tirzepatide be used in humans?
No. Tirzepatide is supplied strictly for in-vitro laboratory research by qualified professionals. It is not for human or veterinary use, and it is not approved by the FDA for any therapeutic purpose.
How is an order for Tirzepatide placed and paid for?
Add Tirzepatide to the cart and check out on the site. Payment is by PayPal or Bitcoin. Orders placed before 2 PM ET are dispatched from the US the same day payment clears; later orders go out the next day. If Bitcoin is unfamiliar, a short guide is linked at checkout.
Related products
More in GLP-1 Receptor Agonists.
